z-logo
Premium
Case report: Cure of chronic infection with hepatitis C virus after 6 weeks of peg‐interferon and ribavirin in a patient co‐infected with HIV
Author(s) -
Rachline Anne,
Palmer Pierre,
Simon François,
Molina JeanMichel
Publication year - 2010
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.21781
Subject(s) - ribavirin , medicine , virology , hepatitis c virus , virus , adverse effect , chronic hepatitis , human immunodeficiency virus (hiv) , viral disease , interferon , pegylated interferon , alpha interferon , immunology
The recommended treatment duration of chronic hepatitis C virus (HCV) in patients infected with human immunodeficiency virus (HIV) is 48 weeks. This report describes a patient co‐infected with HCV genotype 2 and HIV who discontinued HCV therapy after 6 weeks because of adverse events and had a sustained virologic response. J. Med. Virol. 82:1150–1151, 2010. © 2010 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom